Computer-aided detection may be crossing the line from potential to proven value, not only in the clinical realm but in business as well. GE Medical Systems and Kodak Health Imaging are giving this clinical tool unprecedented visibility within their
Computer-aided detection may be crossing the line from potential to proven value, not only in the clinical realm but in business as well. GE Medical Systems and Kodak Health Imaging are giving this clinical tool unprecedented visibility within their organizations. Both have hatched business plans that emphasize the integration of CAD tools into products. GE has even designated a CAD business manager.
“We’re looking at CAD technology across the business,” said Samantha Allison, general manager for women’s healthcare business at GE Medical Systems. “We see a wealth of opportunity there.”
Development work is focused on digital mammography and CAD applications for breast cancer. But that’s just the beginning, according to Allison.
“What comes next is where the opportunity lies: 3-D mammography, contrast-media mammography, pathology-based processing, and fusion with other modalities, she said.”
At Kodak Health Imaging, engineers have been working on CAD applications to help detect lung nodules using digital radiography. The work is defined by Kodak’s increasing emphasis on applications in “information imaging,” such as products that combine imaging and information technology to yield better data management, said Aaron Waitz, chief systems architect for the company.
“Information imaging is a market space where images, information, and the infrastructure that ties them all together are combined,” Waitz said.
CAD fits that concept well, said Ted Taccardi, digital product manager for Kodak. He describes what the company is doing as identifying additional information and making it more obvious to the radiologist.
“We’re trying to help the user get more value out of images through the incremental information that CAD provides,” he said.
Working with R2 Technologies of Los Altos, CA, Kodak is aggressively developing ways to use CAD with its CR and DR systems.
“Where CAD really comes into play and has high value is in screening, where fatigue on the part of the interpreter could be an issue,” Taccardi said. “That’s why both breast cancer and lung nodule fields are good application areas for CAD.”
In addition to specific clinical applications for CAD, the technology could also be applied to image “data mining.” Sophisticated algorithms work in the background, while an image is being interpreted so as to alert radiologists to additional findings that could be relevant.
“This a real opportunity for CAD,” said Jimmy Roehrig, Ph.D., chief science officer at R2 Technologies. “One of the reasons humans miss things is because they’re not looking for them.”
Ultimately, Roehrig said, the CAD model applied to mammography is applicable to a broad range of clinical environments and modalities.
“Any imaging application in which information overload is an issue is potentially an application for CAD,” he said. “If you analyze the information in an image, in the context of a practice where physicians have to review a large number of images very quickly, that’s an environment where a computer can help.”
GE’s Allison concurs.
“CAD flows across the imaging world,” she said. “It doesn’t matter whether it’s in conjunction with MR business, CT, ultrasound, or digital x-ray. It’s really about how you utilize software algorithms to assess the massive quantity of information that’s available in a digital image. That translates across the business.”
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.